Загрузка...
Preclinical development and first-in-human imaging of the integrin α(v)β(6) with [(18)F]α(v)β(6)-Binding Peptide in metastatic carcinoma.
PURPOSE: The study was undertaken to develop and evaluate the potential of an integrin α(v)β(6)-binding peptide (α(v)β(6)-BP) for noninvasive imaging of a diverse range of malignancies with positron emission tomography (PET). EXPERIMENTAL DESIGN: The peptide α(v)β(6)-BP was prepared on solid phase a...
Сохранить в:
| Опубликовано в: : | Clin Cancer Res |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6377828/ https://ncbi.nlm.nih.gov/pubmed/30401687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-2665 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|